Mary Shoemaker
Directeur/Membre du Conseil chez TRAWS PHARMA, INC.
Fortune : 2 141 $ au 30/04/2024
Postes actifs de Mary Shoemaker
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur/Membre du Conseil | 01/04/2020 | - |
| Independent Dir/Board Member | 01/04/2020 | - |
Historique de carrière de Mary Shoemaker
Anciens postes connus de Mary Shoemaker
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | - | 22/05/2020 |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | 01/10/2018 | 01/05/2020 |
| Directeur Général | 01/01/2012 | 01/05/2020 | |
| President | 01/10/2018 | 01/05/2020 | |
| INTERMUNE INC | Sales & Marketing | 06/11/2009 | 01/07/2010 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - | - |
Formation de Mary Shoemaker
| Missouri State University | Undergraduate Degree |
| University of Central Missouri | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
- Bourse
- Insiders
- Mary Shoemaker
- Expérience
